Trial site
Hospital Central de Asturias
- 7running trials
- 6closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Bronchiectasis2 trials
- Multiple myeloma2 trials
- Acute lymphoblastic leukaemia1 trial
- Childhood cancers1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Familial hypercholesterolaemia1 trial
- Heart failure1 trial
- Idiopathic pulmonary fibrosis1 trial
- Liver and biliary tract cancer1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Neuroendocrine tumours1 trial
- and 2 more
- Phase
- Phase 36 trials
- Phase 22 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Completed6 trials
- Not yet recruiting3 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Suspended1 trial
- Lead sponsor
- Boehringer Ingelheim4 trials
- PETHEMA Foundation3 trials
- Annetine Gelijns1 trial
- Bayer1 trial
- Fundación Academia Española de Dermatología1 trial
- and 4 more
Running trials
Not yet recruiting
Not yet recruiting
Elranatamab With Mezigdomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Not yet recruiting
Recruiting
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Recruiting
Spanish Academy of Dermatology and Venereology (AEDV) Melanoma Registry
Active, not recruiting
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)
Active, not recruiting
SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bronchiectasis2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Melanoma1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026